Nicholas Haft - Director, Finch Therapeutics Group, Inc

As of June 15, 2022


What is Nicholas Haft's Net Worth?

The current estimated net worth of Finch Therapeutics Group, Inc's Director, Nicholas Haft, is estimated to be about $2.29M . Nicholas Haft owns about 4,056,907 units of Finch Therapeutics Group, Inc common stock. In the last year at Finch Therapeutics Group, Inc, Nicholas Haft has sold an estimated value of $0 worth.

What is Nicholas Haft's Past Insider Trading?

Nicholas Haft's largest purchase order was 3,993,057 units , worth over $15M on March 25, 2021. In total, Nicholas Haft has made about 3 transactions over a year of their time at Finch Therapeutics Group, Inc. Nicholas Haft usually trades in December, March and June, with the busiest year in 2021. The most recent transaction was a purchase order of 63,850 units , worth over $649.99K on December 22, 2021.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Nicholas Haft's' Mailing Address?

  • Mailing address is C/o Finch Therapeutics Group, Inc. 200 Inner Belt Road, Suite 400 Somerville MA 02143 MA

What are Finch Therapeutics Group, Inc's Past Insider Trades?

Finch Therapeutics Group, Inc's most recent insider trade came on December 22, 2021 by Nicholas Haft who bought 63,850 units worth $649.99K . In the last 10 months, insiders at Finch Therapeutics Group, Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Joseph Vittiglio, Chief Business & Legal Officer,  Marc Blaustein, Chief Operating Officer,  and Nicholas Haft, Director .

Finch Therapeutics Group, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1